Celyad Company
Celyad is a provider of cell therapy treatments with an initial focus on cardiology and oncology.
Estimated Revenue:
$1M to $10M
Funding Status:
IPO
Industry:
CAR-T
Investors Number:
5
Last Funding Date:
2021-12-03
Founded Date:
2007-01-01
Headquarters:
Mont-saint-guibert, Brabant Wallon, Belgium
Total Funding:
146096840
Last Funding Type:
Post-IPO Equity